Skip to Main Content

September 16, 2022   
Health Law Weekly

United States Defends Falsity Theory, Use of Debatable Sub-Regulatory Guidance in Medicare Advantage False Claims Act Suit Against Kaiser Permanente

  • September 16, 2022
  • John Kelly , Barnes & Thornburg LLP
  • Jackie Papish , Barnes & Thornburg LLP
  • A.J. Bolan , Barnes & Thornburg LLP
Scales and gavel

The False Claims Act actions pending against the Kaiser Permanente Consortium members in the U.S. District Court for the Northern District of California concerning Kaiser’s Medicare Advantage risk-adjustment practices are teeing up a possible showdown regarding what constitutes sub-regulatory guidance and when sub-regulatory guidance can support a legal falsity claim.


You must be logged in to access this content.